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Abstract
Fatal neurodegenerative prion diseases are caused by the transmissible PrP
Sc prion agent whose initial replication after
peripheral inoculation takes place in follicular dendritic cells present in germinal centers of lymphoid organs. However,
prion replication also occurs in lymphoid cells. To assess the role of the hematopoietic compartment in neuroinvasion and
prion replication, we generated chimeric mice, on a uniform congenic C57/BL6J background, by bone marrow replacement
with hematopoietic cells expressing different levels of PrP protein. Nine different types of chimeric mice were inoculated
intraperitoneally either with the lymphotropic Rocky Mountain Laboratory (RML) strain or the non lymphotropic ME-7
scrapie strain, at different doses. Here, we clearly demonstrate that overexpression of PrP by the hematopoietic system, or
the lack of PrP expression by the bone marrow derived cells, does not change the incubation time period of the disease,
even when the mice are infected at limiting doses. We conclude that the hematopoietic compartment is more or less
permissive to prion replication, both for RML and ME-7, but does not play a role in neuroinvasion.
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Introduction
After oral exposure to prions, accumulation of infectivity is first
detected in mucosal lymphoid organs. Neuroinvasion occurs later,
and involves the translocation of PrP
Sc via peripheral nerves and its
accumulation in the brain. PrP deficient mice are not susceptible
to prion [1] and the expression levels of PrP
c protein correlate
inversely with prion disease incubation time and disease
progression [2].
The role of the immune system in prion diseases has been
suggested when it was observed that severe combined immuno-
deficient mice, which lack B and T lymphocytes, are resistant to
peripheral prion inoculation, but susceptibility can be restored
after bone marrow (BM) transplantation [3,4]. From these original
observations, several studies have been carried out to characterize
the cell types involved in agent replication before neuroinvasion.
There is a general agreement that follicular dendritic cells
(FDCs) are the principal sites for amplification of PrP
Sc in
lymphoid tissues during the early phase of infection, before the
disease spreads to the nervous system [5,6,7]. FDCs are present in
follicles of any secondary lymphoid organ and belong to the
stromal cells compartments. Recent data on mesenchymal
precursor cells from the peripheral blood, suggest a close
relationship between FDCs and fibroblast-like cells [8]. The
immune system allows the differentiation and maintenance of
FDC network in lymphoid organs by the secretion of cytokines
such as TNFa and lymphotoxins a and b by B cells.
ME-7 and RML strains are the two principal mouse inocula,
which have been used in mouse scrapie models. Although RML
and ME-7 neuroinvasion is dependent upon the presence of
FDCs, these two strains present differences in affinity for bone
marrow (BM) derived cells. Following infection with RML strain,
high levels of infectivity accumulate in spleen in the absence of
PrP
c expression by FDCs so long as PrP
c is expressed by
hematopoietic derived cells, suggesting the lymphotropic nature
of the RML strain [9,10]. Exactly opposite result has been
reported using ME-7 strain as in this case, no infectivity
accumulate in spleen in the absence of PrP
c expression by FDCs
even if the hematopoietic cells express PrP
c [11],[12].
The question is whether prion replication by BM derived cells is
involved in neuroinvasion. For that, we have carried out
experiments using mice on a uniform congenic C57/BL6J
background, reconstituted after lethal irradiation with BM from
three groups of mice expressing different level of PrP
c: (i) mice
where prp gene has been deleted (Prp
0/0 [1]), (ii) wild type mice,
and (iii) mice carrying several copies of prp gene (Tga20 mice [2]).
These mice express 0, 1 or 4–5 times the level of PrP
c respectively,
relative to wild type mice. The animals were inoculated either with
lymphotropic RML strain or ME-7 scrapie strain.
In this work, we clearly show that the level of PrP
c expression in
the hematopoietic compartment does not influence the time course
of the induced disease. Indeed the mice reconstituted with BM
from Prp
0/0 mice have the same incubation time as mice
reconstituted with BM from wild type mice, or from mice
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c, even when inoculated with limiting prion
doses. Although ME-7 strain has been described as a non
lymphotropic strain, we observed infectivity in the spleen of
PrP
0/0 mice reconstituted with BM overexpressing PrP
c. These
results indicate the fact that a cell derived from hematopoietic
compartment can replicate both ME-7 and RML scrapie strain,
but cannot account for neuroinvasion.
Results
PrP
c expression by BM derived cell does not influence the
scrapie incubation period in chimeric mice
Each set of Prp
0/0, Tga20 or B6 congenic mice were
reconstituted with femoral BM from the three same sources.
These combinations led to the generation of nine different types of
chimeric mice for a total of more than 120 animals. We use the
following convention to name those mice groups: when we write
Tga20RB6 mice, this means that Tga20 BM cells have been
injected in B6 mice for hematopoietic reconstitution.
In a first set of experiment, we injected intraperitoneally 100 ml
of a ME-7 inoculum containing 10
25 LogLD50. Wild-type B6
inoculated mice died after 252 days (IQR, 237–267 days) post-IP
inoculation. As expected, the inoculated Tga20 mice have a
shorter incubation period 130 days (IQR, 123–135 days) than the
B6. This is explained by the fact that PrP
c expression is 5 to 6
times higher in Tga20 mice than B6 wild type animals [2]. The
chimeric mice on the B6 background (B6RB6, n=4; Tga20RB6,
n=6 and the Prp
0/0RB6, n=2) presented the same incubation
period (261 days; IQR, 232–295 days/278 days; IQR, 234–315
days/260 days, respectively) as wild-type B6. Similarly the
incubation period of the chimeric mice on the Tga20 background
were not significantly different than the Tga20 mice, whatever the
origin of the BM used for the reconstitution: Tga20RTga20,
n=6, 140 days (IQR, 124–158 days), B6RTga20, n=7, 144 days
(IQR, 116–161 days), and Prp
0/0 RTga20, n=4, 150 days (IQR,
139–155 days).
When injected with the lymphotropic RML strain (10
24
LogLD50) (Fig. 1b), wild-type B6 inoculated mice died after 201
days (IQR, 192–207 days) post-IPinoculation.Similar incubation
times were observed in the chimeric mice B6RB 6 ,n = 5 ,1 8 8
days (IQR, 174–196 days), in the Tga20RB 6m i c e ,n = 5 ,1 9 6
days (IQR, 183–196 days), and in the Prp
0/0RB6, n=8, 185
days (IQR, 175–192 days). The Tga20 mice died after 99 days
(IQR, 94–106 days) post-IP inoculation, compared to 92 days
(IQR, 91–97 days) for the chimeric Tga20RTga20 (n=8), 91
days (IQR, 87–93 days) for the B6RTga20 mice (n= 8) and 92
days (IQR, 91–94 days) for Prp
0/0RTga20 (n=8). As expected,
none of the chimeric mice harboring a Prp
0/0 genetic background
developed a clinical disease, for lack of expression of PrP
c
protein [1].
From these experiments, we could conclude that the expression
level of the PrP
c by the hematopoietic cells does not influence the
scrapie incubation period. However it has been suggested that,
when using high doses of inoculum, the PrP
Sc might be able to
bypass the lymphoreticular system and invade directly the
peripheral nervous system [3], therefore the PrP
c expression of
BM derived cells would have little influence on the incubation
time. In agreement with this idea, amplification of infectivity in
PrP positive BM derived cells might be necessary in order to
achieve neuroinvasion after inoculation with lower doses of
prions.
To test this hypothesis we have inoculated intraperitoneally the
chimeric mice on the Tga20 background withlimiting doses ofthe
lymphotropic RML strain (10
27 LogLD50). Accumulation of the
RML strain in lymphoid organs has been extensively described
[9,10], in contrast to the ME-7 strain [11,12]. If RML
amplification by BM derived cells is required for neuroinvasion,
therefore we would expect to observe a difference in the
incubation period between Tga20 mice reconstituted with BM
overexpressing PrP
c and Tga20 mice reconstituted with BM
sampled from Prp
0/0 mice. As shown in Fig. 2, no difference in
incubation period was observed whatever the origin of the BM
Figure 1. PrP
c overexpression by the hematopoietic system does not play a role in neuroinvasion. B6 (black) or Tga20 (grey) mice were
lethally irradiated, reconstituted with femoral bone marrow cells from B6 (square), Tga20 (triangle) or Prp
0/0 (circle) mice and inoculated either with
the ME-7 (10
25 LogLD50) (A) or RML (10
24 LogLD50) (B) prion scrapie strains. The incubation periods are expressed as days post-inoculation (DPI). P
values were obtained using the Kruskal-Wallis ANOVA test. In panel (A), P value of 0.93 was determined for the reconstituted B6 mice group and of 0.9
for the reconstituted Tga20 group. In panel (B), the P values were of 0.17 and of 0.32 for reconstituted B6 and Tga20 mice groups, respectively.
doi:10.1371/journal.pone.0013166.g001
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165 days), Tga20RTga20, n=11, 139 days (IQR, 119–179days),
and Prp
0/0RTga20, n=7, 160 days (IQR, 126–224 days). Since
the amount of inoculum was very low, three inoculated mice did
not develop clinical disease, while the seven mice that developed
scrapie showed longer and more dispersed incubation periods
than mice inoculated with high infective doses (Fig. 1). These
results demonstrate that the replication of lymphotropic RML
strain in BM derived cells does not play a critical role in
neuroinvasion.
ME-7 infectivity can be detected in the spleen of PrP
0/0
mice reconstituted with Tga20 BM
Since RML strain replicates in BM derived cells [13] while ME-
7 does not [5], the spleens of PrP
0/0 chimeric mice were analyzed
for the presence of prion infectivity. As expected, PrP
0/0 chimeric
mice did not develop a clinical disease, and therefore have been
sacrificed at the end of the experiments (450 days post-
inoculation). Because low levels of infectivity could not be detected
by western blotting analysis, we performed a bioassay by
intracerebral inoculation of Tga20 mice with these spleen extracts.
Tga20 mice inoculated with spleen extract from both
Tga20RPrp
0/0 (n=7) and B6RPrp
0/0 (n=6) died of scrapie
after 95 days (IQR, 75–105 days) and 113 days (IQR, 111–116
days) post-inoculation, respectively (Fig. 3). These results corrob-
orate reported data [13]. In contrast, no Tga20 mice infected with
a crude extract from the spleen of B6RPrp
0/0 ME-7 infected mice
developed the disease after 450 days post-inoculation (n=6). This
is in agreement with previous data [5]. However, 6/6 Tga20 mice
inoculated with the spleen of Tga20RPrp
0/0 infected mice have
developed a typical clinical disease, with accumulation of PrP
Sc in
brain (data not shown). This indicates that ME-7 strain can
replicate in the hematopoietic compartment at a low level, but
only when BM derived cells overexpress PrP
c.
Discussion
Prion diseases are caused by a conformational change in widely
expressed PrP
c protein, leading to the formation and accumulation
of PrP aggregates. Although prion diseases cause degeneration of
the central nervous system, the presence of infectivity can be
detected in lymphoid tissues at a very early stage of the disease
after peripheral inoculation [14]. Studies have shown that severely
immunodeficient mice lacking B and T lymphocytes are resistant
to peripheral prion infection, but susceptibility can be restored
following BM transplantation [3], [4]. Further studies point out
the prominent role of FDCs, which are not BM derived cells, in
the initial replication of prion [5,6,7]. Even if infectivity has been
demonstrated in lymphoid organs and blood, the role of the
hematopoietic compartment still remains unclear. The question is
whether prion replication by BM derived cells is involved in
neuroinvasion.
Besides differences in scrapie strains used, interpretation of these
sophisticated experiments is complicated by variations in the
amounts of inoculum, and the genetic background of the mice
utilized [15]. The sanitary status might also interfere with
interpretation of the results. As a matter of fact, mice infection
with specific pathogen and/or opportunistic agents could lead to
chronic inflammation that is known to modify prion infection [16].
Similarly the fact that in all the studies published the mice were
not on a congenic background could not guarantee a full
histocompatibility situation.
In order to avoid possible graft host reaction, our strategy was to
create chimeric mice on the B6 background expressing different
levels of PrP
c in the hematopoietic compartment. In addition we
performed embryo transfers to obtain animals devoid of
pathogens, to limit inflammatory chronic infection that could
interfere with the pathophysiology of the disease [16]. After lethal
irradiation, Prp
0/0, Tga20 or C57/BL6J congenic mice were
Figure 2. No difference in disease incubation period is
observed in Tga20 chimeric mice inoculated with limiting
doses of the RML strain (10
27 LogLD50). Tga20 mice were lethally
irradiated, reconstituted with femoral bone marrow cells from B6
(square), Tga20 (triangle) or Prp
0/0 (circle) mice and inoculated with the
RML prion scrapie strains. The incubation periods are expressed as days
post-inoculation (DPI). At this low dose, only 7/10 mice developed
scrapie. A P value of 0.19 was obtained using the Kruskal-Wallis ANOVA
test when comparing the three groups of mice.
doi:10.1371/journal.pone.0013166.g002
Figure 3. PrP
c overexpression by the hematopoietic cells favors
prion agent replication in the spleen of reconstituted Prp
0/0
mice. Spleen of Prp
0/0 mice lethally irradiated reconstituted with
femoral bone marrow cells from Tga20 (inverse triangle) or B6 (circle)
mice and inoculated with RML (black) or ME-7 (grey) strains were
sampled 450 days post-inoculation and subsequently inoculated to
Tga20 mice. Days post-inoculation (DPI) are represented. A P value of
0.001 was obtained using the Mann-Whitney t-test when comparing the
Tga20RPrp
0/0 and B6RPrp
0/0 mice.
doi:10.1371/journal.pone.0013166.g003
Prion in Chimeric Mice
PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13166reconstituted with BM from each of the other mice to yield nine
different types of chimeric animals. The chimeric mice models
used in this study were not designed to assess the role of FDCs.
These cells do not derive from hematopoietic precursors, and it
has been clearly observed that mice defective for FDCs present a
delay in the development of the clinical diseases, showing that the
initial replication of infectivity in FDCs is critical for neuroinvasion
[5,6,7]. Nevertheless some Prp
Sc strains such as RML show
lymphotropism and their infectivity may involve a contribution of
hematopoietic cells [9,10]. In this situation the level of PrP
expression by hematopoietic cells should influence the incubation
period. Conversely, no effect should be expected when using ME-
7, a non lymphotropic strain [11],[12].
PrP
c is widely expressed in various types of tissues and cells,
including hematopoietic stem cell [17]. Tga20 mice that carry 60
copies a ‘half genomic’ sequence of the prion protein gene, express
approximately 5–6 fold higher levels of PrP
c in the central nervous
system. In these mice, the PrP
c overexpression has also been
observed both in CD3 positive thymocytes [18] and splenocytes
[18,19,20] indicating that Tga20 BM derived cells overexpressed
PrP
c.
Using high doses of either ME-7 or RML scrapie agents, we
observed that the PrP status of the hematopoietic compartment
did not modify the incubation time of the disease. These results are
congruent with some previous partial data [21,22]. To explain
this, it has been proposed that high doses of inoculums may bypass
the lymphoreticular system and directly invade the central nervous
system via peripheral nerves, with no amplification in lymphoid
tissues [3]. However, when chimeric mice were inoculated with
limiting doses of RML, we observed that the level of PrP
c
expression by BM derived cells did not affect the time course of
scrapie infection. Therefore it is clear that the replication of prion
in the hematopoietic compartment has no influence on neuroinva-
sion, even when the strain accumulates in lymphoid cells. This
could indicate, as previously reported [23], that circulating cells
are unlikely to play a role in neuroinvasion. However this does not
exclude that cells such as dendritic cells could spread infectivity to
other cells or to peripheral nerves, which in turn are involved in
neuroinvasion [24]. If BM cells do not play a significant direct role
in neuroinvasion, in situations such as contaminated blood
products, these cells could transfer infectivity as previously
reported [25–26]. As a summary, possible routes of prion
neuroinvasion after peripheral exposure have been schematized
in Fig. 4.
An unexpected result from this study concerns the paradigm of
Brown and Blutter. When inoculated with lymphotropic RML
strain, wild-type bone marrow cells transplanted in PrP deficient
mice can restore accumulation and replication of prion in spleen,
indicating that cells other than FDCs can replicate prion in the
secondary lymphoid tissues [9]. By contrast Brown et al. reported a
diametrically opposite outcome of similar experiment when
reconstituted mice were inoculated with ME-7 strain [5]. We
confirm these data; however we have evidenced infectivity in the
spleen tissue of chimeric mice reconstituted with BM derived cells
sampled from Tga20, when the ME-7 infectivity titer was low.
This demonstrates that both ME-7 and RML can replicate in cells
derived from hematopoietic compartment, other than FDCs.
Methods
Ethics Statement
Animals were housed according with the French Ethical
Committee (Decree 87–848) and European Community Directive
86/609/EEC. Experiments were carried out under the supervision
Figure 4. Routes of prion neuroinvasion after peripheral exposure. (a) Natural prion diseases are often acquired via peripheral exposure
such as orally, or through skin lesions. How prion reaches its peripheral targets is not known. (b) Direct invasion of the central nervous system might
occur with high doses of prion or exposure to neuroinvasive strains. (c) Whereas after exposure to limiting doses of infectivity or less neuroinvasive
strains, replication in FDCs in the germinal centers of local lymphoid tissues might be necessary prior to neuroinvasion via closely associated nerve
fibers. FDCs are dependent on the presence of B lymphocytes for maturation signals, such as lymphotoxin. (d) Haematogenous spread of infectivity
via circulating bone marrow derived cells would not play a role in direct neuroinvasion.
doi:10.1371/journal.pone.0013166.g004
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approved by the Direction des Services Ve ´te ´rinaires de l’Ise `re (Nu
A 38 516 10006). Before surgical procedure and prion inoculation,
mice were anesthetized with a mixture injected intra-peritoneally
of ketamine hydrochloride (Imalgen 500, Merial, 25 mg/kg body
weight) and xylasine (Rompun, Bayer Healthcare, 12.5 mg/kg
body weight).
Mice
In order to circumvent tolerance problems after hematopoietic
transfer, the speed congenic technology was used to generate mice
with the same C57/BL6J genetic background for the two following
strains: Prp
0/0 prion deficient mice [1], and Tga20 mice [2] that
were obtained from Pr. Charles Weissmann (Scripps Institute,
Florida). The technology consists in using genetic markers
throughout the genome to speed up ‘recovery’ of the recipient
genome in the backcrossing phase of the construction of a
congenic strain as described [27]. Tga20 mice, Prp
0/0 and C57/
BL6J, hereafter called B6 (Charles River Laboratories, Lyon), were
housed in ventilated cages and maintained under specific
pathogen-free conditions. Scrapie inoculated mice were housed
in a biosafety laboratory level 3 animal care facility in cages placed
in ventilated and negative pressure insulator.
Bone marrow chimeras
Chimeric mice (.120) were reconstituted by injecting into the
tail vein 5 to 10610
6 femoral BM cells into lethally irradiated (9.5
Gy) recipient 4 weeks old mice. B6 mice were reconstituted with
BM cells from either B6, Tga20 or Prp
0/0 mice; Tga20 mice
reconstitution was performed with Tga20, B6 or Prp
0/0 BM cells;
and Prp
0/0 were reconstituted with BM sampled from Tga20, B6
or Prp
0/0 mice. The day following reconstitution, mice were
treated with ciprofloxacine (0.1 mg/ml in drinking water) for ten
days. Successful hematopoietic reconstitution was assessed 2
months after engraftment: CD3, CD4, CD8 lymphocytes total
numbers and PrP
c expression by these cells were determined by
flow cytometry analysis (data not shown). Failure led to the death
of the mice within two weeks following irradiation.
Source of the scrapie agent and inoculation
The ME-7 and the RML prion strains were maintained by
successive inoculations into B6 mice. The scrapie inocula were
prepared from brain tissues collected from terminally sick mice.
The brain homogenate was prepared in PBS (10% w/v), and the
presence of PrP
Sc confirmed by western blot analysis as described
in [28]. More than 100 mice were successfully reconstituted and
intraperitoneally inoculated with 100 ml of inoculum. Endpoint
titrations were performed as described in [10].
Measurement of the incubation period
For ethical reasons, the mice were sacrificed at the onset of the
disease rather then waiting for their death. The onset was defined
by the clear appearance of at least three of the following
neurological symptoms: trembling, prostration, feet clasping when
lifted, increased tone of the tail. The incubation period was taken
as the time from inoculation to the euthanasia of the mice. Mice
were monitored three times a week, beginning two months after
inoculation. Tissues were collected, and frozen (280uC) for
subsequent western blot analysis, or reinoculation into Tga20
mice. Incubation period data was expressed as median and Inter
Quartile Range (IQR). Differences in incubation periods were
tested by the Kruskal-Wallis ANOVA test (Fig. 1 & 2) or the
Mann-Whitney t-test (Fig. 3). In all comparisons, the level of
significance was set at 0.05.
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